Zendesk, Inc. ZEN 深 滬
已收盤 11-21 16:00:00 美东时间
77.48
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 77.48
- 總市值 96.08亿
- 52周最高 130.83
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 54.16
- 委 比 0.00%
- 總股本 1.24亿
- 歷史最高 166.60
- 量 比 0
- 振 幅 0.00%
- 歷史最低 11.06
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ZENVIA Reports Q2 2025 Results
Transition to Zenvia Customer Cloud moving on as expected, with revenues from these services up 23% YoY CPaaS revenues still fueling top line Continued strict expense control SÃO PAULO, Se...
09-11 06:30
征拓首次推出电动货运自行车概念
太阳能创新企业征拓（Zendure）宣布拓展其智能ZEN+家庭能源管理系统（HEMS），新增精准负载控制、数据驱动型优化能源管理及语音助手等功能。ZEN+家庭生...
09-05 15:15
Zentek’s Albany Graphite Corp. Secures $500,000 Grant for Purification Project
Zentek ( ($TSE:ZEN) ) just unveiled an update. Albany Graphite Corp., a subsidi...
09-02 20:44
Reported Friday, Genentech And Alnylam Initiate ZENITH Phase III Trial Evaluating Zilebesiran in 11,000 Patients With Uncontrolled Hypertension
– Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 –– In the Phase II KARDIA-3 study, presented today as a late breaker at
09-02 16:09
Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
Zenas BioPharma and Royalty Pharma have announced a $300 million funding partnership for the development and commercialization of obexelimab, a potential treatment for IgG4-Related Disease. This includes an initial $75 million payment and further installments tied to Phase 3 trial results, FDA approval, and potential indications in other autoimmune diseases like lupus and multiple sclerosis. Obexelimab is a bifunctional monoclonal antibody design...
09-02 11:05
医疗板块回暖+中报营收利润双高增，归创通桥（2190.HK）凭什么领跑创新械企？
2025年以来，沉寂已久的港股医药行业迎来强势反弹。富途显示，今年恒生医疗保健指数累计涨幅已突破100%，不仅如同一记强心针点燃市场热情，更引发市场对行业走势的...
08-27 11:40
Zentek Ltd. Prepares for September 2025 Shareholder Meeting
An announcement from Zentek ( ($TSE:ZEN) ) is now available. Zentek Ltd. announ...
08-26 03:07
Merck to Present New Cardiovascular Disease and Pulmonary Hypertension Research at ESC 2025 in Madrid
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced that new clinical trial and outcomes research data will be presented at the European Society of Cardiology Congress (ESC) 2025 in Madrid,
08-25 18:49
Zenith Energy Completes Coupon Payments on Euro Medium Term Notes
Zenith Energy ( ($GB:ZEN) ) has shared an update. Zenith Energy Ltd. has succes...
08-15 16:27
千帧电竞！七彩虹主板解锁《无畏契约》极致体验
《无畏契约》作为热门的英雄战术射击游戏，全球月活跃玩家数已突破1.5亿，国内玩家数量也在迅猛增长。高刷显示器、磁轴键盘还有高DPI鼠标等电竞外设的普及，极大提高...
08-15 15:21
